Machine learning for comprehensive forecasting of Alzheimer’s Disease progression

Coalition Against Major Diseases, Abbott, Alliance for Aging Research, Alzheimer’s Association, Alzheimer’s Foundation of America, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Critical Path Institute, CHDI Foundation, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Forest Research Institute, Genentech, Inc., GlaxoSmithKline, Johnson & Johnson, National Health Council, Novartis Pharmaceuticals Corporation, Parkinson’s Action Network, Parkinson’s Disease Foundation, Pfizer, Inc., sanofi-aventis. Collaborating Organizations: Clinical Data Interchange Standards Consortium (CDISC), Ephibian, Metrum Institute.

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Dive into the research topics of 'Machine learning for comprehensive forecasting of Alzheimer’s Disease progression'. Together they form a unique fingerprint.

Medicine & Life Sciences